Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
Clinical trial NCT01434316 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01434316
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-11
- Primary completion
- 2023-03-28
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.